A Study to Learn About How Trumenba Vaccine Shots Work Against Gonorrhea Infection in Teenagers and Young Adults in the United States.
Public ClinicalTrials.gov record NCT05873751. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Effect of Trumenba on Gonococcal Infections in Adolescents and Young Adults in the United States: A Retrospective Cohort Study
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Brief Summary: The main purpose of the study is to learn about how well Trumenba vaccine shot works against gonorrhea infection. This study looks at data records from a database in the United States. This study includes patient's data from the database who: * Are 15-30 years old. * Have received at least one dose of Trumenba and a MenACWY vaccine or who have received only MenACWY vaccine. This data has already been collected in the past and is being studied between April and June of 2023.
Study identification
- NCT ID
- NCT05873751
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 1,307,378 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 15 Years to 30 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 23, 2023
- Primary completion
- Mar 30, 2024
- Completion
- Mar 30, 2024
- Last update posted
- Apr 16, 2025
2023 – 2024
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer | New York | New York | 10001 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Gonorrhea trials
Other public records listing Gonorrhea. Sorted by last update posted; newest first. Not a recommendation.
- NCT06738407: Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections Recruiting
- NCT05678556: Effectiveness of Relationship Education for Reducing HIV Incidence Among Men Who Have Sex With Men Recruiting
- NCT06428643: A Seek, Test, and Treat Intervention to Reduce Chlamydia Trachomatis Disparities Recruiting
- NCT06766331: Integrated Care Versus Usual Care for Opioid Use Disorder and Infectious Diseases in Veterans Not yet recruiting
- NCT07464236: Improving Clinic Delivery of HIV-related Anal Health Services Not yet recruiting
- NCT06951438: Assessing Acceptability and Feasibiity of STI Self-swab Testing, to be Offered at the Time of Telemed Medication Abortion Provision Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05873751, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 16, 2025 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05873751 live on ClinicalTrials.gov.